BlueLinx (BXC) had the highest return between January 10, 2018 and March 30, 2018 by a small-cap US stock, returning 214.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
BlueLinx (BXC) | 1/10/2018 - 3/30/2018 | 214.58% |
Geron (GERN) | 1/10/2018 - 3/30/2018 | 127.27% |
POET Technologies (POET) | 1/10/2018 - 3/30/2018 | 123.53% |
Acm Research (ACMR) | 1/10/2018 - 3/30/2018 | 122.49% |
Iovance Biotherapeutics (IOVA) | 1/10/2018 - 3/30/2018 | 100% |
Spyre Therapeutics (SYRE) | 1/10/2018 - 3/30/2018 | 93% |
Gyre Therapeutics (GYRE) | 1/10/2018 - 3/30/2018 | 75.39% |
American Public Education (APEI) | 1/10/2018 - 3/30/2018 | 74.09% |
Ameresco (AMRC) | 1/10/2018 - 3/30/2018 | 65.61% |
Perpetua Resources (PPTA) | 1/10/2018 - 3/30/2018 | 63.56% |
Zevra Therapeutics (ZVRA) | 1/10/2018 - 3/30/2018 | 62.89% |
Novavax (NVAX) | 1/10/2018 - 3/30/2018 | 55.56% |
Rocket Pharmaceuticals (RCKT) | 1/10/2018 - 3/30/2018 | 53.44% |
Syndax Pharmaceuticals (SNDX) | 1/10/2018 - 3/30/2018 | 50.11% |
Heron Therapeuti (HRTX) | 1/10/2018 - 3/30/2018 | 47.59% |
Galiano Gold (GAU) | 1/10/2018 - 3/30/2018 | 47.06% |
SolarEdge Technologies (SEDG) | 1/10/2018 - 3/30/2018 | 42.16% |
Penguin Solutions (PENG) | 1/10/2018 - 3/30/2018 | 41.67% |
TechTarget, Inc Common Stock (TTGT) | 1/10/2018 - 3/30/2018 | 40.99% |
Hello (MOMO) | 1/10/2018 - 3/30/2018 | 40% |
Bandwidth (BAND) | 1/10/2018 - 3/30/2018 | 39.93% |
SurModics (SRDX) | 1/10/2018 - 3/30/2018 | 39.89% |
Herbalife Nutrition (HLF) | 1/10/2018 - 3/30/2018 | 39.16% |
Collegium Pharmaceutical (COLL) | 1/10/2018 - 3/30/2018 | 38.86% |
Zymeworks Inc Common Stock (ZYME) | 1/10/2018 - 3/30/2018 | 37.37% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
